Takayasu Arteritis clinical trials

Explore recruiting takayasu arteritis clinical trials.

Recruiting takayasu arteritis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Takayasu Arteritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

STARS - Prospective, bayesian, randomized, controlled, open-label, parallel-group, phase II interventional study evaluating efficacy and safety of secukinumab versus standard of care in active severe Takayasu patients

France

Therapeutic exploratory (Phase II) EU CTIS Study details

INTOReTAK - Multicentre, randomized, prospective trial evaluating the efficacy and safety of Infliximab to tocilizumab in refractory or relapsing Takayasu arteritis - INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Takayasu Arteritis trials by city

Takayasu Arteritis in Toronto Takayasu Arteritis in Vancouver Takayasu Arteritis in Montreal Takayasu Arteritis in Calgary Takayasu Arteritis in Edmonton Takayasu Arteritis in Ottawa Takayasu Arteritis in Winnipeg Takayasu Arteritis in Quebec City Takayasu Arteritis in Hamilton Takayasu Arteritis in Kitchener Takayasu Arteritis in London Takayasu Arteritis in Halifax Takayasu Arteritis in New York Takayasu Arteritis in Los Angeles Takayasu Arteritis in Chicago Takayasu Arteritis in Houston

Takayasu Arteritis clinical trials

Recruiting takayasu arteritis studies right now

Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission

A Pilot Study in Severe Patients With Takayasu Arteritis.

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Also recruiting in Europe

STARS - Prospective, bayesian, randomized, controlled, open-label, parallel-group, phase II interventional study evaluating efficacy and safety of secukinumab versus standard of care in active severe Takayasu patients

INTOReTAK - Multicentre, randomized, prospective trial evaluating the efficacy and safety of Infliximab to tocilizumab in refractory or relapsing Takayasu arteritis - INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritis

Takayasu Arteritis trials by city

Other conditions